Official 2024 U.S. DOL Form 5500 summary for Takeda Pharmaceuticals U.s.a., INC (Baxalta Incorporated And Subsidiaries Pension Plan · EIN 13-4013710 · PN 003): $392.92M net assets, 482 active participants, and $64.02 per $10,000 (64.02 bps).
| Plan Sponsor | Takeda Pharmaceuticals U.s.a., INC |
|---|---|
| Filing Identifier | Baxalta Incorporated And Subsidiaries Pension Plan · EIN 13-4013710 · PN 003 |
| Plan Category & State | Defined Benefit & Cash Balance (PA) |
| Asset-Size Peer Cohort | $100M-$500M |
| Plan Net Assets (2024) | $392.92M |
| Active Participants | 482 |
| Direct Admin Fee Rate | $64.02 per $10,000 (64.02 bps) |
| Cohort Peer Median | $9.75 per $10,000 (9.75 bps) |
| Primary Recordkeeper / Provider | WTW (Willis Towers Watson) |
| Schedule H Line 4a Remittance | Timely Employer Remittance (0 reported on Line 4a) |
Browse all 78,373 plans & Schedule C vendors · Methodology · Meru AI
Verified federal filings reconciled for Takeda across sibling Meru AI platforms.